QuantTB

QuantTB identifies and quantifies individual Mycobacterium tuberculosis strains and resistance-associated variants from whole-genome sequencing datasets to resolve mixed infections and heteroresistance.


Key Features:

  • SNP-Based Methodology: QuantTB utilizes single nucleotide polymorphism (SNP) markers to identify and quantify individual strains within whole genome sequencing samples.
  • High Resolution and Sensitivity: Capable of distinguishing communities differing by fewer than 25 SNPs and detecting strains in samples with coverage as low as 1×.
  • Strain Identification and Quantification: Provides lists of identified Mycobacterium tuberculosis strains with relative abundances and predicts resistance-conferring mutations and heteroresistance for drugs present in the sample.
  • Performance Validation: Validated on simulated datasets and on 50 paired clinical isolates, outperforming other metagenomic strain identification tools in detection and quantification and yielding results concordant with manual curation.

Scientific Applications:

  • Detection of Mixed Infections: By leveraging whole-genome sequencing and SNP markers, detects and quantifies mixed Mycobacterium tuberculosis infections.
  • Differentiation Between Relapse and Re-infection: Analyzes strain multiplicity and genomic differences to distinguish relapse from reinfection.
  • Heteroresistance Pattern Identification: Identifies heteroresistance patterns and resistance-conferring mutations within samples to inform antibiotic resistance dynamics.

Methodology:

QuantTB employs SNP markers to determine the combination of strains that best explain the allelic variation observed in a sample.

Topics

Details

License:
GPL-3.0
Programming Languages:
Python
Added:
1/18/2021
Last Updated:
1/31/2021

Operations

Publications

Anyansi C, Keo A, Walker BJ, Straub TJ, Manson AL, Earl AM, Abeel T. QuantTB – a method to classify mixed Mycobacterium tuberculosis infections within whole genome sequencing data. BMC Genomics. 2020;21(1). doi:10.1186/s12864-020-6486-3. PMID:31992201. PMCID:PMC6986090.

PMID: 31992201
PMCID: PMC6986090
Funding: - National Institute of Allergy and Infectious Diseases: U19AI110818